Latest Headlines

  1. GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment
    1/8/2018

    GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointly develop and co-market digital clinical decision support solutions. The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180107005109/en/ GE, Roche Enter Partnership to develop an industry-first digital platform, using advanced analytics to provide workflow solutions

  2. Histogenics Selects Skyland Analytics’ Centralized Limit Management Software For Process Data Management And CPV Planning
    1/3/2018

    Skyland Analytics announced recently that Histogenics has deployed Skyland’s Centralized Limit Management™ (CLM™) software to streamline management of critical data in its process development, product scale-up and commercial manufacturing operations.

  3. Juno Therapeutics And Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
    12/20/2017

    Juno Therapeutics (NASDAQ: JUNO) and Thermo Fisher Scientific have entered into a partnership for Juno to use Thermo Fisher's Cell Therapy Systems (CTS) activation reagents in the manufacturing of its chimeric antigen receptor T cell (CAR T) therapies.

  4. New Scholarship Honors Women In Life Sciences
    12/18/2017

    The Carolyn E. Green Scholarship was unveiled today to further leadership opportunities for women in the life science industry. Created to honor the memory of Carolyn Green, who was a leading industry voice and advocate, the new scholarship will better the life science industry by supporting post-graduate efforts at accredited educational institutions around the world.

  5. Pall Life Sciences Commits To Innovative Technology Advances, Building Key Partnerships To Advance The Drug Production Industry In 2018
    12/13/2017

    Pall Corporation, a global leader in filtration, separation and purification, has strengthened their commitment to advancing the drug production industry through key technology innovations and partnerships leading in to 2018.

  6. Sartorius Stedim Biotech Launches New Versions Of Data Analytics Software Solutions
    12/7/2017

    SIMCA® and SIMCA®-online software updates in the Umetrics™ Suite help manufacturing industries make better business decisions and optimize process control.

  7. bluebird bio (BLUE) Acquires Manufacturing Facility In North Carolina And Executes Multiple Global Supply Agreements
    11/29/2017

    bluebird bio, Inc., a clinical-stage company committed to developing potentially transformative gene and cell therapies for severe genetic diseases and T cell-based immunotherapies for cancer, recently announced it has acquired a 125,000-square foot manufacturing facility in Durham, North Carolina.

  8. GE Healthcare Acquires Bioprocessing Start-Up Puridify
    11/24/2017

    GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production.

  9. New Stax™ mAx Clarification Platform from Pall Life Sciences Delivers Robust, Accelerated Performance Across Multiple mAb Processes
    11/21/2017

    Pall Corporation, a global leader in filtration, separation and purification, is formally introducing the Stax mAx clarification platform, a robust solution for the economic clarification of monoclonal antibody cell cultures without centrifugation or process additives. The single-use harvesting platform features a 4-layer concept, and has been optimized to maintain performance as cell density and viability change to minimize the impact of process variability between batches. Media configurations are available in many formats to scale directly from bench-top testing up to large-scale clinical production.

  10. RiboBio And GE Healthcare Enter Into A Strategic Partnership For Oligonucleotide Drug Development And Manufacturing
    11/21/2017

    At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony